D
Soleno Therapeutics, Inc. SLNO
$48.12 -$0.91-1.85% NASDAQ
Recommendation
Prev Close
$48.12
Volume
163
Avg Vol (90D)
1,934,244
Market Cap
$2.58B
Dividend & Yield
--
52-Week Range
$41.50 - $90.32
P/E (TTM)
--
EPS (TTM)
-$1.85
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
How Does Wolfe Research's Support Shape Soleno Therapeutics' (SLNO) Credibility Amid Heightened Scrutiny?
12/2/2025 - Simply Wall St
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. ...
12/1/2025 - GuruFocus
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
12/1/2025 - Globe Newswire
Handelsbanken Fonder AB Acquires Shares of 10,400 Soleno Therapeutics, Inc. $SLNO
11/30/2025 - MarketBeat
Franklin Resources Inc. Buys New Shares in Soleno Therapeutics, Inc. $SLNO
11/30/2025 - MarketBeat
Analyst Dismisses ViCAT XR Safety Fears, Expects Strong Growth Despite Recent Stock Weakness
11/30/2025 - Insider Monkey
Soleno Therapeutics (SLNO, $50.45) Stochastic Oscillator left the overbought zone on November 28, 2025
11/29/2025 - Tickeron - Stocks
Soleno Therapeutics (NASDAQ:SLNO) Shares Up 8.9% - What's Next?
11/26/2025 - MarketBeat
Soleno Therapeutics (SLNO, $49.77) entered Uptrend as Momentum indicator ascends above 0 level on Nov 25, 2025
11/26/2025 - Tickeron - Stocks
Soleno Therapeutics (SLNO, $49.77) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 25, 2025
11/26/2025 - Tickeron - Stocks
Soleno Therapeutics (SLNO, $49.77) Stochastic Oscillator left the oversold zone on November 25, 2025
11/26/2025 - Tickeron - Stocks
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns
11/25/2025 - Yahoo! Finance: News
Soleno Therapeutics (SLNO, $45.91) Stochastic Oscillator left the oversold zone on November 24, 2025
11/25/2025 - Tickeron - Stocks
A Look at Soleno Therapeutics (SLNO) Valuation Following $100 Million Share Buyback Announcement
11/25/2025 - Simply Wall St
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. ...
11/24/2025 - GuruFocus
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
11/24/2025 - Globe Newswire
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
11/24/2025 - GuruFocus
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
11/24/2025 - Globe Newswire
Soleno Therapeutics, Inc. $SLNO Shares Purchased by Geode Capital Management LLC
11/24/2025 - MarketBeat
Ensign Peak Advisors Inc Grows Stock Holdings in Soleno Therapeutics, Inc. $SLNO
11/24/2025 - MarketBeat
Soleno Therapeutics, Inc. $SLNO Shares Purchased by Westfield Capital Management Co. LP
11/21/2025 - MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) Upgraded at Wolfe Research
11/21/2025 - MarketBeat
Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns
11/21/2025 - Insider Monkey
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
11/20/2025 - PR Newswire
Soleno Therapeutics (SLNO, $47) entered Uptrend as Momentum indicator ascends above 0 level on Nov 19, 2025
11/20/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$98.68M
EBITDA (TTM)
-$82.26M
EBIT (TTM)
-$84.27M
Net Income (TTM)
-$78.45M
Balance Sheet
Total Assets (Q)
$599.90M
Total Debt (Q)
$52.66M
Total Liabilities (Q)
$105.09M
Book Value Per Share (Q)
$9.21
Cash Flow
Cash from Operations (TTM)
-$25.90M
Cash from Investing (TTM)
-$69.98M
Cash from Financing (TTM)
$294.12M
Net Change in Cash (TTM)
$198.25M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
0.53
7-Day Total Return
6.66%
30-Day Total Return
-28.33%
60-Day Total Return
-31.47%
90-Day Total Return
-43.56%
Year to Date Total Return
5.26%
1-Year Total Return
-5.95%
2-Year Total Return
66.26%
3-Year Total Return
4,855.20%
5-Year Total Return
67.07%
52-week Low
Jan 15, 2025 - $41.50
52-week High
Jul 09, 2025 - $90.32
Valuation
Market Cap
$2.58B - Mid Cap
Enterprise Value
$2.08B
Price/Sales (TTM)
26.78
Price/Book (Q)
5.22
Dividends and Shares
Shares Outstanding
54.92
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
soleno.life
Phone Number
650 213 8444
Address
100 Marine Parkway
Redwood City, CA 94065
Country
United States
Year Founded
1999
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed